Adam Schoen has over a decade of experience representing life science and medical device companies. His practice focuses on implementation of patent strategies to further business objectives and business goals. Adam’s practice is multidisciplinary, encompassing all aspects of patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis, intellectual property due diligence and licensing. Adam works with public and private companies, investors and academic institutions.

Adam has experience across the life sciences industry, working with therapeutics companies, biologics companies, diagnostic companies and medical device companies. He works with a variety of technologies, such as small molecule therapeutics, biologics (including immunotherapeutics), next generation sequencing technologies, droplet based technologies, diagnostics (including cancer and fertility diagnostics), medical device technology (ophthalmology, cardiology, orthopedics, neurology, spine), medical imaging technology (IVUS and OCT), mass spectrometry, digital health products, near field communication technology and semiconductor technology. He manages patent portfolios of all sizes and develops strategies to maximize and protect intellectual property rights in both the United States and foreign jurisdictions.

Prior to law school, Adam was a scientist of analytical chemistry for ArQule Inc., a combinatorial chemistry and drug discovery company, and a scientist at Millennium Pharmaceuticals, Inc.


New England School of Law – J.D., magna cum laude, 2006
Cornell University – B.S., 1999

Bar Admissions

Admitted, Massachusetts Bar
Registered Patent Attorney, U.S. Patent and Trademark Office
Speaking Engagements